Divergent Effects of Ovarian Steroids on Neuronal Survival during Experimental Allergic Encephalitis in Lewis Rats-Reference-Cited by-同舟云学术

Divergent Effects of Ovarian Steroids on Neuronal Survival during Experimental Allergic Encephalitis in Lewis Rats

Published:2001-10 Issue:2 Volume:171 Page:272-284
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Hoffman G.E.,Le W.W.,Murphy A.Z.,Koski C.L.

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference62 articles.

1. Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons;Alcazar;Neurosci. Lett.,1998

2. Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis;Alcazar;J. Neuroimmunol.,2000

3. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype;Ando;Cell Immunol.,1989

4. Effects of estrogen, progestin and combined estrogen-progestin oral contraceptive preparations on experimental allergic encephalomyelitis;Arnason;Trans. Am. Neurol. Assoc.,1969

5. Anti-oxidative neuroprotection by estrogens in mouse cortical cultures;Bae;J. Korean Med. Sci.,2000

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnancy Is Associated with Impaired Transcription of Human Endogenous Retroviruses and of TRIM28 and SETDB1, Particularly in Mothers Affected by Multiple Sclerosis;Viruses;2023-03-09

2. Tibolone restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis;Journal of Neuroendocrinology;2021-12-27

3. 17β-Estradiol Reduces Demyelination in Cuprizone-fed Mice by Promoting M2 Microglia Polarity and Regulating NLRP3 Inflammasome;Neuroscience;2021-05

4. Progress in progestin-based therapies for neurological disorders;Neuroscience & Biobehavioral Reviews;2021-03

5. Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease;Frontiers in Neuroendocrinology;2020-04